Rocket Lab USA, Inc. (RKLB) Bundle
Stifel Nicolaus fixe un objectif de prix de 85 $ pour Rocket Lab USA
Le 21 décembre 2025, Stifel Nicolaus a publié un objectif de cours de $85 pour Rocket Lab USA (NASDAQ : RKLB). Cet objectif indique un potentiel de hausse de 20.5% du prix de négociation actuel de $70.52.
Le titre a connu une hausse intrajournalière de 17.7%, représentant un changement de $10.60. L'activité de négociation du 21 décembre 2025 a vu le titre fluctuer entre un minimum de $60.75 et un maximum de $70.55. Volume total des transactions atteint 52,76 millions actions.
Rocket Lab USA a une capitalisation boursière d'environ 36,18 milliards de dollars. Depuis son introduction en bourse en 2021, la société a vu le cours de ses actions augmenter quintuple. Les ventes ont augmenté de près décuplé alors que l’entreprise s’aligne sur les tendances à long terme de l’industrie spatiale.
Le titre reste en dessous de son plus haut de 52 semaines de $73.97 mais continue d'attirer l'attention des investisseurs. Des informations supplémentaires sont disponibles concernant le RKLB-histoire-mission-propriété et le RKLB. Les analystes continuent d'évaluer RKLB-santé-financière et RKLB-investisseur-profile.
Rocket Lab USA, Inc. (RKLB) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.